Plasma DYRK1A as a novel risk factor for Alzheimer’s disease

Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass

(2014) Latif Rachdi et al.   DIABETOLOGIA

Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice

(2013) Asma Tlili et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?

(2012) Breland Smith et al.   ACS Chemical Neuroscience

BDNF and DYRK1A Are Variable and Inversely Correlated in Lymphoblastoid Cell Lines from Down Syndrome Patients

(2012) Asma Tlili et al.   MOLECULAR NEUROBIOLOGY

Drug repositioning for Alzheimer's disease

(2012) Anne Corbett et al.   NATURE REVIEWS DRUG DISCOVERY

DYRK1A: A master regulatory protein controlling brain growth

(2012) Fayçal Guedj et al.   NEUROBIOLOGY OF DISEASE

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease

(2011) Leonardo Cruz de Souza et al.   BRAIN

Alzheimer's disease

(2011) Clive Ballard et al.   LANCET

Dyrk1a activates antioxidant NQO1 expression through an ERK1/2–Nrf2 dependent mechanism

(2011) Christophe Noll et al.   MOLECULAR GENETICS AND METABOLISM

Altered regulation of tau phosphorylation in a mouse model of down syndrome aging

(2011) Olivia Sheppard et al.   NEUROBIOLOGY OF AGING

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias

(2010) L. C. de Souza et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

(2009) Pieter Jelle Visser et al.   LANCET NEUROLOGY

Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor Ikappa B alpha

(2009) Julien Hamelet et al.   MOLECULAR GENETICS AND METABOLISM

Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome

(2008) Fei Liu et al.   FASEB JOURNAL

Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease

(2007) Soo-Ryoon Ryoo et al.   JOURNAL OF NEUROCHEMISTRY